Literature DB >> 7773570

Apolipoprotein B messenger RNA editing: insights into the molecular regulation of post-transcriptional cytidine deamination.

N O Davidson1, S Anant, A J MacGinnitie.   

Abstract

A site-specific cytidine deamination (cytidine to uridine) in nuclear apolipoprotein B messenger RNA creates a translational stop codon that produces apolipoprotein B48. This process is mediated by an enzyme composed of distinct subunits, including apolipoprotein B messenger RNA editing enzyme catalytic polypeptide-1 and additional complementation factors. The apolipoprotein B messenger RNA editing enzyme catalytic polypeptide-1 is expressed ubiquitously in the rat, but is largely confined to the small intestine in humans and rabbits. By contrast, complementation activity is present in tissues that neither express nor edit apolipoprotein B messenger RNA.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7773570     DOI: 10.1097/00041433-199504000-00002

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  6 in total

1.  An AU-rich sequence element (UUUN[A/U]U) downstream of the edited C in apolipoprotein B mRNA is a high-affinity binding site for Apobec-1: binding of Apobec-1 to this motif in the 3' untranslated region of c-myc increases mRNA stability.

Authors:  S Anant; N O Davidson
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

2.  Increased hepatic synthesis and accumulation of plasma apolipoprotein B100 in copper-deficient rats does not result from modification in apolipoprotein B mRNA editing.

Authors:  F Nassir; F Giannoni; A Mazur; Y Rayssiguier; N O Davidson
Journal:  Lipids       Date:  1996-04       Impact factor: 1.880

3.  Lipoprotein clearance mechanisms in LDL receptor-deficient "Apo-B48-only" and "Apo-B100-only" mice.

Authors:  M M Véniant; C H Zlot; R L Walzem; V Pierotti; R Driscoll; D Dichek; J Herz; S G Young
Journal:  J Clin Invest       Date:  1998-10-15       Impact factor: 14.808

4.  Absence of hyperlipidemia in LDL receptor-deficient mice having apolipoprotein B100 without the putative receptor-binding sequences.

Authors:  Lance A Johnson; Michael K Altenburg; Rosemary L Walzem; Lori T Scanga; Nobuyo Maeda
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-07-10       Impact factor: 8.311

Review 5.  APOBEC3s: DNA-editing human cytidine deaminases.

Authors:  Tania V Silvas; Celia A Schiffer
Journal:  Protein Sci       Date:  2019-07-10       Impact factor: 6.993

6.  New Insights Into the Lineage-Specific Expansion and Functional Diversification of Lamprey AID/APOBEC Family.

Authors:  Yan Chen; Lingjie Luo; Lisi Deng; Xiaoxue Tian; Shangwu Chen; Anlong Xu; Shaochun Yuan
Journal:  Front Immunol       Date:  2022-03-11       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.